Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-002828
Filing Date
2011-03-29
Accepted
2011-03-29 17:00:47
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2203077z10-k.htm 10-K 1271211
2 EX-4.7 a2203077zex-4_7.htm EX-4.7 109707
3 EX-4.8 a2203077zex-4_8.htm EX-4.8 136511
4 EX-23.1 a2203077zex-23_1.htm EX-23.1 3699
5 EX-31.1 a2203077zex-31_1.htm EX-31.1 6669
6 EX-31.2 a2203077zex-31_2.htm EX-31.2 6690
7 EX-32.1 a2203077zex-32_1.htm EX-32.1 5446
8 G7137.JPG g7137.jpg GRAPHIC 94252
9 G124541.JPG g124541.jpg GRAPHIC 30908
  Complete submission text file 0001047469-11-002828.txt   1713634
Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals Inc (Filer) CIK: 0001411158 (see all company filings)

EIN.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34973 | Film No.: 11719311
SIC: 2834 Pharmaceutical Preparations